Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968581585> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W1968581585 endingPage "132" @default.
- W1968581585 startingPage "129" @default.
- W1968581585 abstract "We report a case of increase in serum tumour markers CA 125 and CA 19·9 induced by cyclic combined hormone replacement therapy (HRT). A 52-year-old Caucasian post-menopausal woman presented with a slight enlargement of the right ovary and uterine fibromyomatosis. She was taking HRT for 4 years in a cyclic combined regimen of 2 mg oestradiol with 1 mg cyproterone acetate. The serum tumour markers occasionally measured were in normal range except CA 19·9 (997 U/mL; normal values 0·0–37) and CA 125 (85 U/mL; normal values 0·0–35). However, on one occasion, the CA 19·9 and CA 125 were high and then showed persistently high values (1005 and 81·3 U/mL, respectively). Radiodiagnostic investigations excluded any malignancies and a hysteroscopy showed endometrial thickening. After discontinuation of HRT, CA 125 levels returned to normal after 1 month, whereas CA 19·9 took 6 months to do so. Four months after the beginning subsequent therapy with over-the-counter phyto-oestrogens a new serum test showed an increase in CA 19·9 but CA 125 remained within the normal range. Phyto-oestrogen therapy was then interrupted and 1 month later CA 19·9 returned to normal. In this case, cyclic HRT was the probable cause of CA 19·9 and CA 125 increase. Positive dechallenge and subsequent CA 19·9 increase after phyto-oestrogen intake seem to confirm the role of oestrogens as the cause of the endometrial thickening through hormonal imbalance. Increased CA 19·9 and CA 125 levels in benign gynaecological conditions may be a source of misdiagnosis of malignant disease." @default.
- W1968581585 created "2016-06-24" @default.
- W1968581585 creator A5005919863 @default.
- W1968581585 creator A5005950730 @default.
- W1968581585 creator A5017900514 @default.
- W1968581585 creator A5061031953 @default.
- W1968581585 creator A5079187407 @default.
- W1968581585 creator A5088995507 @default.
- W1968581585 date "2009-02-01" @default.
- W1968581585 modified "2023-09-23" @default.
- W1968581585 title "Increased levels of CA 125 and CA 19·9 serum tumour markers following cyclic combined hormone replacement therapy" @default.
- W1968581585 cites W1976168100 @default.
- W1968581585 cites W1976460112 @default.
- W1968581585 cites W1987438172 @default.
- W1968581585 cites W2028285191 @default.
- W1968581585 cites W2045253644 @default.
- W1968581585 cites W2057780839 @default.
- W1968581585 cites W2065460570 @default.
- W1968581585 cites W2065861950 @default.
- W1968581585 cites W2067978628 @default.
- W1968581585 cites W2069851999 @default.
- W1968581585 cites W2093476744 @default.
- W1968581585 cites W2130075738 @default.
- W1968581585 cites W2136940189 @default.
- W1968581585 cites W2137298008 @default.
- W1968581585 cites W6654383 @default.
- W1968581585 doi "https://doi.org/10.1111/j.1365-2710.2008.00995.x" @default.
- W1968581585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19125912" @default.
- W1968581585 hasPublicationYear "2009" @default.
- W1968581585 type Work @default.
- W1968581585 sameAs 1968581585 @default.
- W1968581585 citedByCount "12" @default.
- W1968581585 countsByYear W19685815852015 @default.
- W1968581585 countsByYear W19685815852017 @default.
- W1968581585 countsByYear W19685815852018 @default.
- W1968581585 countsByYear W19685815852019 @default.
- W1968581585 countsByYear W19685815852021 @default.
- W1968581585 countsByYear W19685815852022 @default.
- W1968581585 countsByYear W19685815852023 @default.
- W1968581585 crossrefType "journal-article" @default.
- W1968581585 hasAuthorship W1968581585A5005919863 @default.
- W1968581585 hasAuthorship W1968581585A5005950730 @default.
- W1968581585 hasAuthorship W1968581585A5017900514 @default.
- W1968581585 hasAuthorship W1968581585A5061031953 @default.
- W1968581585 hasAuthorship W1968581585A5079187407 @default.
- W1968581585 hasAuthorship W1968581585A5088995507 @default.
- W1968581585 hasBestOaLocation W19685815851 @default.
- W1968581585 hasConcept C126322002 @default.
- W1968581585 hasConcept C134018914 @default.
- W1968581585 hasConcept C2777155358 @default.
- W1968581585 hasConcept C2777911890 @default.
- W1968581585 hasConcept C2778715236 @default.
- W1968581585 hasConcept C2779279991 @default.
- W1968581585 hasConcept C2780159708 @default.
- W1968581585 hasConcept C71315377 @default.
- W1968581585 hasConcept C71924100 @default.
- W1968581585 hasConceptScore W1968581585C126322002 @default.
- W1968581585 hasConceptScore W1968581585C134018914 @default.
- W1968581585 hasConceptScore W1968581585C2777155358 @default.
- W1968581585 hasConceptScore W1968581585C2777911890 @default.
- W1968581585 hasConceptScore W1968581585C2778715236 @default.
- W1968581585 hasConceptScore W1968581585C2779279991 @default.
- W1968581585 hasConceptScore W1968581585C2780159708 @default.
- W1968581585 hasConceptScore W1968581585C71315377 @default.
- W1968581585 hasConceptScore W1968581585C71924100 @default.
- W1968581585 hasIssue "1" @default.
- W1968581585 hasLocation W19685815851 @default.
- W1968581585 hasLocation W19685815852 @default.
- W1968581585 hasOpenAccess W1968581585 @default.
- W1968581585 hasPrimaryLocation W19685815851 @default.
- W1968581585 hasRelatedWork W1965461558 @default.
- W1968581585 hasRelatedWork W1982195695 @default.
- W1968581585 hasRelatedWork W1984341416 @default.
- W1968581585 hasRelatedWork W1987621412 @default.
- W1968581585 hasRelatedWork W2050709457 @default.
- W1968581585 hasRelatedWork W2062690991 @default.
- W1968581585 hasRelatedWork W2068406290 @default.
- W1968581585 hasRelatedWork W2075762636 @default.
- W1968581585 hasRelatedWork W2100489643 @default.
- W1968581585 hasRelatedWork W2142416343 @default.
- W1968581585 hasVolume "34" @default.
- W1968581585 isParatext "false" @default.
- W1968581585 isRetracted "false" @default.
- W1968581585 magId "1968581585" @default.
- W1968581585 workType "article" @default.